Table 1.

Baseline characteristics of the study population by CKD stage.

	CKD stage
	2	3	4	5
	Median (SD)	Median (SD)	Median (SD)	Median (SD)
cfDNA (ng/mL)	8.4 (2.80)	7.9 (3.87)	6.8 (3.05)	7.7 (4.86)
hsCRP (mg/L)	1.28 (2.38)	1.79 (2.25)	1.58 (1.85)	1.14 (1.66)
vWF (%)	126 (26.5)	135 (35.6)	138.5 (27.9)	129 (22.4)
IL-1β (pg/mL)	0.21 (2.3)	0.15 (0.78)	0.16 (0.79)	0.17 (0.55)
IL-6 (pg/mL)	1.57 (3.8)	1.3 (5.2)	1.7 (2.2)	1.52 (3.7)
IL-8 (pg/mL)	2.16 (3.7)	2.66 (5.1)	2.94 (4.3)	2.91 (6.01)
TNFα (pg/mL)	2.30 (11.3)	5.40 (8.5)	4.66 (9.64)	5.40 (11.7)